Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 5/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | MMP2 | P08253 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.54 |
| ▸ | IDO1 | P14902 | 1/20 | 0.54 |
| ▸ | CFTR | P13569 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.52 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Anthranilic Acid SCHEMBL362171 | 0.97 | ALDH1A1 (0.65) | ALDH1A1ALOX15MAPTGAAMMP2 | |
| Anthranilic Acid SCHEMBL3110791 | 0.97 | ALDH1A1 (0.65) | ALDH1A1ALOX15MAPTGAAMMP2 | |
| Anthranilic Acid SCHEMBL29802554 | 0.97 | ALDH1A1 (0.65) | ALDH1A1ALOX15MAPTGAAMMP2 | |
| Anthranilic Acid SCHEMBL2953168 | 0.97 | ALDH1A1 (0.65) | ALDH1A1ALOX15MAPTGAAMMP2 | |
| Anthranilic Acid SCHEMBL675 | 0.97 | ALDH1A1 (0.65) | ALDH1A1ALOX15MAPTGAAMMP2 | |
| Anthranilic Acid SCHEMBL29365173 | 0.97 | ALDH1A1 (0.65) | ALDH1A1ALOX15MAPTGAAMMP2 | |
| Anthranilic Acid SCHEMBL2961107 | 0.97 | ALDH1A1 (0.65) | ALDH1A1ALOX15MAPTGAAMMP2 | |
| Anthranilic Acid SCHEMBL3406307 | 0.95 | ALDH1A1 (0.62) | ALDH1A1ALOX15MAPTGAAMMP2 | |
| Anthranilic Acid SCHEMBL7654765 | 0.95 | ALDH1A1 (0.62) | ALDH1A1ALOX15MAPTGAAMMP2 | |
| Anthranilic Acid SCHEMBL21585878 | 0.95 | ALDH1A1 (0.62) | ALDH1A1ALOX15MAPTGAAMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0478199-B1 | Polyvinyl chloride resin composition for powder molding | SUMITOMO CHEMICAL CO (JP) | 1997-06-25 | — | — | EP | claimed |
| EP-0478199-A2 | Polyvinyl chloride resin composition for powder molding | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1992-04-01 | — | — | EP | claimed |
| CN-1012682-B | POLYVINYL CHLORIDE RESIN COMPOSITION FOR POWDER MOLDING | SUMITOMO CHEMICAL CO (JP) | 1991-05-29 | — | — | CN | claimed |
| US-4861816-A | Polyvinyl chloride resin composition for powder molding | SUMITOMO CHEMICAL COMPANY (JP) | 1989-08-29 | — | — | US | claimed |
| CN-87105970-A | The poly (vinyl chloride) resin composition that is used for powder molding | — | 1988-08-10 | — | — | CN | claimed |
| CN-110366597-B | Blood profiling with protease inhibitors | 善威生物私人有限公司 | 2024-03-29 | — | — | CN | disclosed |
| US-20240060997-A1 | Blood Preparation and Profiling | SANGUI BIO PTY LTD (AU) | 2024-02-22 | — | — | US | disclosed |
| US-11693006-B2 | Blood profiling with protease inhibitors | SANGUI BIO PTY. LTD (AU) | 2023-07-04 | — | — | US | disclosed |
| EP-4009047-A1 | BLOOD PREPARATION AND PROFILING | Sangui Bio Pty. Ltd (AU) | 2022-06-08 | — | — | EP | disclosed |
| US-11243218-B2 | Blood preparation and profiling | Sangui Bio Pty Ltd. (AU) | 2022-02-08 | — | — | US | disclosed |
| CN-114019171-A | Blood preparation and profiling | 善威生物私人有限公司 | 2022-02-08 | — | — | CN | disclosed |
| US-11235112-B2 | Inhalable dry powders | PULMATRIX OPERATING COMPANY, INC. (US) | 2022-02-01 | — | — | US | disclosed |
| EP-2410981-A2 | DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES | Pulmatrix, Inc. (US) | 2012-02-01 | — | — | EP | disclosed |
| WO-2010111680-A2 | DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES | PULMATRIX, INC. (US) | 2010-09-30 | — | — | WO | disclosed |
| EP-0478199-B1 | Polyvinyl chloride resin composition for powder molding | SUMITOMO CHEMICAL CO (JP) | 1997-06-25 | — | — | EP | disclosed |
| US-5432222-A | Nonstaining, releasibility | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-07-11 | — | — | US | disclosed |
| EP-0478199-A2 | Polyvinyl chloride resin composition for powder molding | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1992-04-01 | — | — | EP | disclosed |
| CN-1012682-B | POLYVINYL CHLORIDE RESIN COMPOSITION FOR POWDER MOLDING | SUMITOMO CHEMICAL CO (JP) | 1991-05-29 | — | — | CN | disclosed |
| US-4861816-A | Polyvinyl chloride resin composition for powder molding | SUMITOMO CHEMICAL COMPANY (JP) | 1989-08-29 | — | — | US | disclosed |
| CN-87105970-A | The poly (vinyl chloride) resin composition that is used for powder molding | — | 1988-08-10 | — | — | CN | disclosed |